SICKLE CELL APPROVED
DEAD

Serial Number

87015102

Owner

The 316 Group, LLC

Attorney

Tammy Hui

First Use Date

May 7, 2017

Filing Date

Apr 26, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SICKLE CELL APPROVED Trademark

Serial Number: 87015102 • Registration: 5498358

SICKLE CELL APPROVED is a trademark filed by The 316 Group, LLC on April 26, 2016. The trademark is classified under Class 41 (Education & Entertainment). The application is currently no longer active.

Owner Contact Info

The 316 Group, LLC (3 trademarks)

Arlington, VA 22203

Entity Type: 16

Trademark Details

Filing Date

April 26, 2016

Registration Date

June 19, 2018

First Use Anywhere

May 7, 2017

First Use in Commerce

March 12, 2018

Published for Opposition

April 4, 2017

Cancellation Date

January 3, 2025

Goods & Services

arranging of seminars; charitable donation services, namely, providing educational classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; conducting workshops and seminars in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing live and on-line classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing non-downloadable webinars in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing on-line classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, providing classes, seminars, workshops, and training in the fields of sickle cell disease and other blood-borne illnesses/diseases; education services, namely, training educators in the field of sickle cell disease and other blood-borne illnesses/diseases and providing curricula in connection therewith; educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of training material in connection therewith; educational services, namely, conducting informal on-line programs in the fields of sickle cell disease and other blood-borne illnesses/diseases, and printable materials distributed therewith; educational services, namely, conducting informal programs in the fields of sickle cell disease and other blood-borne illnesses/diseases, using on-line activities and interactive exhibits, and printable materials distributed therewith; educational services, namely, conducting programs in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting classes, seminars, workshops, and training for parents, instructors, companies, and caretakers of individuals with sickle cell disease and other blood-borne illnesses in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of training material in connection therewith; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, developing curriculum for others in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing displays and exhibits in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing educational speakers in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing online instruction in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, providing online instruction in the field of sickle cell disease and other blood-borne illnesses/diseases via an online website; educational services, namely, providing classes, seminars, workshops, and training in the fields of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, teacher training in the field of sickle cell disease and other blood-borne illnesses/diseases provided on a real-time basis during classroom instruction; organization of seminars; providing classes, workshops, seminars and camps in the field of sickle cell disease and other blood-borne illnesses/diseases; providing on-line training classes, seminars, and workshops in the field of sickle cell disease and other blood-borne illnesses/diseases; training services in the field of sickle cell disease and other blood-borne illnesses/diseases; workshops and seminars in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting on line and telephonic instruction and courses in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in the field of sickle cell disease and other blood-borne illnesses/diseases; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of course materials in connection therewith in printed or electronic format; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of course material in connection therewith; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of course and educational materials in connection therewith ; educational services, namely, conducting classes, seminars, workshops, and training in the field of sickle cell disease and other blood-borne illnesses/diseases and distribution of educational materials in connection therewith; educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of sickle cell disease and other blood-borne illnesses/diseases

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 3, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 19, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 27, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 27, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 27, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 27, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 27, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 27, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 17, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 16, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 11, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 4, 2018 AITU
USE AMENDMENT FILED
Apr 16, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 16, 2018 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2017 EXRA
SOU EXTENSION 1 GRANTED
Nov 21, 2017 EX1G
SOU EXTENSION 1 FILED
Nov 21, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 21, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 16, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 16, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 16, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 16, 2017 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2016 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2016 NWOS
NEW APPLICATION ENTERED
Apr 29, 2016 NWAP